Patent details

EP1691830 Title: BOTULINUM TOXIN THERAPY FOR SKIN DISORDERS

Basic Information

Publication number:
EP1691830
PCT Application Number:
PCT/US/2004/041327
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP048136303
PCT Publication Number:
WO/2005/056050
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BOTULINUM TOXIN THERAPY FOR SKIN DISORDERS
French Title of Invention:
TRAITEMENT DES TROUBLES CUTANES AU MOYEN DE TOXINE BOTULINIQUE
German Title of Invention:
BOTULINUSTOXIN-THERAPIE FÜR HAUTERKRANKUNGEN
SPC Number:

Dates

Filing date:
08/12/2004
Grant date:
15/08/2007
EP Publication Date:
15/08/2007
PCT Publication Date:
23/06/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/08/2006
EP B1 Publication Date:
15/08/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/12/2007
Expiration date:
08/12/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/12/2004
 
 

Name:
ALLERGAN INC.
Address:
2525 Dupont Drive, Irvine, California 92612, United States (US)

Inventor

Name:
FIRST Eric, R.
Address:
United States (US)

Priority

Priority Number:
731973
Priority Date:
09/12/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/48;
Filing date Document type Number of pages